Indiva Limited
Indiva Limited
Your view on NDVAF
Overview
What the company does, where it operates, and who runs it.
About Indiva Limited
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Not available
- Headquarters
- CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Not available
- Headquarters
- CA
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA and Artisan Batch brands, as well as provides production and manufacturing services to peer entities.
The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Past Reports
Historical coverage archive.
*Indiva Limited had paid FRC a fee for research coverage and distribution of reports. This fee creates a potential conflict of interest which readers should consider.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Indiva Limited. Starting points for Indiva Limited: EPS -$0.03 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Indiva Limited. Indiva Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Indiva Limited. Trailing twelve-month EPS for Indiva Limited stands at -$0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrJun 2024 | Next QtrSep 2024 | Current YearFY Dec 2024 | Next YearFY Dec 2025 |
|---|---|---|---|---|
| Avg. estimate | CAD 0.00 | CAD 0.00 | CAD 0.00 | CAD 0.00 |
| Low estimate | CAD 0.00 | CAD 0.00 | CAD 0.00 | CAD 0.00 |
| High estimate | CAD 0.00 | CAD 0.00 | CAD 0.00 | CAD 0.00 |
| No. of analysts | 0 | 0 | 1 | 0 |
| Year-ago EPS | −CAD 0.01 | −CAD 0.001 | −CAD 0.031 | — |
| Growth | +100.0% | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrJun 2024 | Next QtrSep 2024 | Current YearFY Dec 2024 | Next YearFY Dec 2025 |
|---|---|---|---|---|
| Avg. estimate | CAD 10.39M | CAD 11.23M | CAD 43.07M | CAD 46.53M |
| Low estimate | CAD 10.39M | CAD 11.23M | CAD 43.07M | CAD 46.53M |
| High estimate | CAD 10.39M | CAD 11.23M | CAD 43.07M | CAD 46.53M |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago revenue | CAD 7.51M | CAD 9.79M | CAD 37.57M | — |
| Growth | +38.5% | +14.8% | +14.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Indiva Limited. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| DOGPDogecoin Cash, Inc. | Healthcare | Medical - Healthcare Information Services | $2.5M | ||
| HDRPFEpsilon Healthcare Limited | Healthcare | Drug Manufacturers - Specialty & Generic | $544,746 | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| LVZPFLivzon Pharmaceutical Group Inc. | Healthcare | OTC | $6.1B | ||
| LYPHFLuye Pharma Group Ltd. | Healthcare | OTC | $1.5B | ||
| MAJIMarijuana Inc. | Healthcare | OTC | $1.8M | ||
| MCOAMarijuana Company of America, Inc. | Healthcare | OTC | $2.2M | ||
| MCUJFMedicure Inc. | Healthcare | OTC | $8.6M | ||
| MDDVFMedical Developments International Limited | Healthcare | OTC | $41.8M | ||
| MEDIFMediPharm Labs Corp. | Healthcare | OTC | $21.1M | ||
| MILCMillennium Sustainable Ventures Corp. | Healthcare | OTC | $3,300 | ||
| MILFF1CM Inc. | Healthcare | OTC | $13.0M | ||
| MJARFMJardin Group, Inc. | Healthcare | OTC | $90,140 | ||
| MJNAMedical Marijuana, Inc. | Healthcare | OTC | $1.1M | ||
| MKGAFMerck KGaA | Healthcare | OTC | $66.6B | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Indiva Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Indiva Limited executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Indiva Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Indiva Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Indiva Limited. Coverage tracks Indiva Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Indiva Limited.